CORONARY ARTERY BYPASS GRAFTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Coronary artery bypass grafting (CABG) is a type of surgery that improves blood flow to the heart. It is used to treat people with severe coronary artery disease that has not responded well to other treatments. The main purpose of the surgery is to bypass narrow or blocked sections of the coronary arteries with healthy blood vessels, usually taken from the chest, arm, or leg of the patient. This improves blood flow and oxygen delivery to the heart muscle, thus, relieving symptoms of chest pain or pressure (angina) and reducing the risk of heart attack. Coronary artery bypass grafting is one of the most commonly performed cardiac surgeries worldwide.

 Market Dynamics:

Global coronary artery bypass grafting market growth is driven by increasing prevalence of heart disease across both developing and developed nations. High blood pressure, diabetes, obesity and lack of physical activity has increased cardiovascular cases, thus, boosting demand for CABG procedures. Favorable reimbursement policies for cardiac treatments in developed countries and growing medical tourism in emerging economies can offer opportunities for market growth. However, development of innovative minimally invasive endovascular techniques for coronary revascularization can hamper the market growth as these result in less complications and faster recovery times as compared to open-chest CABG surgery. The market players could overcome this restraint by integrating robotic and navigation technologies to make CABG safer and less complex.

Key Features of the Study:

- This report provides in-depth analysis of the global coronary artery bypass grafting market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year

- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

- It profiles key players in the global coronary artery bypass grafting market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

- Key companies covered as a part of this study include Medtronic, Terumo, MAQUET, Boston Scientific, C. R. Bard and Edwards Lifesciences

- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

- Global coronary artery bypass grafting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronary artery bypass grafting market

Detailed Segmentation-

• By Technology
  
  • Off-pump CABG
  • On-pump CABG
  • Others
• By Product
  
  • Grafts
    
    • Saphenous vein grafts  
    • Internal thoracic artery grafts      
    • Other grafts
  • Retractors
  • Heart positioners     
  • Tissue stabilizers
  • Others
• By End User
  • Hospitals
  • Cardiology Clinics
  • Ambulatory surgical centers
  • Academic & Research institute
  • Other
• By Region           
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Abbott Laboratories
  • Medtronic
  • Boston Scientific Corporation
  • LivaNova PLC
  • Edwards Lifesciences Corporation
  • Maquet Holding B.V. & Co. KG
  • TERUMO CORPORATION
  • Guidant
  • Vitalitec
  • Novadaq
  • KARL STORZ
  • Ethicon US, LLC (Johnson & Johnson)
  • NeoGraft Technologies, Inc.
  • Genesee Biomedical Inc.
  • Hancock Jaffe Laboratories, Inc.
  • VasoPrep Surgical
  • Dextera Surgical Inc.
  • Neograft Inc.